UV Safety Awareness Month: Identifying Non-Melanoma Skin Cancer

July 09, 2018
Category: Blog

Did you know non-melanoma skin cancer (NMSC) affects more than three million people and kills 2,000 people each year?

 

But it doesn’t have to. If caught early, NMSC can be easily treated and have few negative consequences, however, it is critical to understand some of the main causes of NMSC, such as excessive exposure to ultraviolent rays (UVRs). With July being UV Safety Awareness Month, it’s the perfect time to discuss the impact of ultraviolent rays (UVRs) and h... Continue reading

Tags: Skin Cancer Skin eBx Physicians Patients
July_Blog_Image_2.jpg

IORT for the Treatment of Breast Cancer: An Invaluable Solution

June 12, 2018
Category: Blog

Did you know that every year in the U.S. more than 60,000 women are diagnosed with early-stage breast cancer? These numbers are daunting, but there are innovative technologies in the marketplace today that not only lower costs for patients and the overall U.S. healthcare system, but also provide patients with increased treatment alternatives.

 

Our team recently released findings of a Cost Effectiveness and Resource Allocation study that found intraoperative radiation therapy (IORT) to be the pr... Continue reading

Tags: Breast Cancer IORT Physicians Patients
IORT_the_treatment_of_breast_cancer_2.jpg

Skin Cancer Awareness Month: How to Protect and Detect Skin Cancer

May 23, 2018
Category: Blog

Not only is May Skin Cancer Awareness Month, it’s also Ultraviolet Awareness Month, providing us with an invaluable opportunity to learn more about harmful ultraviolet rays (UVRs) and how we can protect our skin, even in the winter months.

 

First, some fast facts. According to the American Academy of Dermatology, it is estimated that approximately 9,500 people in the U.S. are diagnosed with skin cancer every day. This means more people are diagnosed with skin cancer each year in the U.S. th... Continue reading

Tags: Skin Cancer Skin eBx Physicians Patients
2018_skin_cancer_awareness_month.jpg

Key Takeaways from 2018 Medical Meetings

May 09, 2018
Category: Blog

Trade show season is here! While these events are great for bringing all professionals of a specific industry together to network and share trends, they can often be daunting and filled with days of meetings, negotiations and presentations. Nonetheless, the data and information presented at trade shows – especially in the healthcare space – can be crucial for providers.

 

As always at Xoft, we aim to keep you updated on the information most valuable to our industry and your specific pract... Continue reading

Tags: Breast Cancer IORT Gynecological Cancer GYN eBx Physicians
NCoBC_1.jpg

iCAD Announces Presentation of Positive Clinical Data on Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers at ESTRO 37

April 19, 2018
Category: Press Releases

Company to showcase advanced, multi-platform electronic brachytherapy (eBx) technology in booth 6800

Nashua, N.H. and Barcelona, Spain (ESTRO Booth 6800) (April 19, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that researchers from Hospital Universitario Miguel Servet in Zaragoza, Spain will pres... Continue reading

World Cancer Day: Raising Awareness and Education of the Disease

February 02, 2018
Category: Blog

According to the American Cancer Society, last year alone there were an estimated 1,688,780 new cancer cases diagnosed and 600,920 cancer deaths in the U.S. These numbers are devastating, but are also why each of us at Xoft come to work every single day. In fact, our company was founded with the sole purpose of improving and expanding patient access to lifesaving treatm... Continue reading

Tags: Breast Cancer IORT Skin Cancer Skin eBx Gynecological Cancer GYN eBx Physicians Patients
xoft_globe_wide.jpg

An Innovative Treatment Option for Early-Stage Breast Cancer

January 19, 2018
Category: Blog

A new clinical study shows how intraoperative radiation therapy (IORT) can reduce radiation side effects and save breast cancer patients ,500 annually.

It’s no surprise that spending on healthcare is rising faster than... Continue reading

Tags: Breast Cancer IORT Physicians Patients
img-An-Innovative-Treatment-Option-for-Early-Stage-Breast-Cancer.jpg

How to Avoid, Detect, and Treat Skin Cancer Year-Round

December 12, 2017
Category: Blog

No matter what time of year it is or where you live, harmful ultraviolet rays (UVRs) are present year-round, and are the primary cause of skin cancer. Surprisingly, more women are diagnosed with skin cancer each year than breast cancer. In fact, according to SkinCancer.org, over the past three decades, more people have had skin cancer than all other cancers combined.

Continue reading

Tags: Skin Cancer Skin eBx Physicians Patients
sunscreen-in-winter-730x430.jpg

Two Centers from The US Oncology Network Adopt iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Non-Melanoma Skin Cancer

December 12, 2017
Category: Press Releases

Prominent cancer centers expand portfolio of patient-centric treatment solutions with Xoft’s innovative, painless, scar-free solution

NASHUA, N.H., (December 12, 2017) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions... Continue reading

iCAD Announces Study Demonstrating Economic and Health Benefits of Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer Treatment

December 07, 2017
Category: Press Releases

Lifetime cost-effectiveness analysis reveals 0 million annual cost savings, less radiation exposure and better quality of life for patients compared to external beam radiation therapy

NASHUA, N.H., (December 7, 2017) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the results of a landmark study that showed the bene... Continue reading

Painless, non-invasive treatment for skin cancer now available

November 29, 2017
Category: Blog

Skin cancer is the most common type of cancer in the U.S.

Many people are familiar with melanoma, which often appears as an irregular shaped mole, but non-melanoma skin cancer is the most common form of skin cancer. It af... Continue reading

Tags: Skin Cancer Skin eBx Physicians Patients
Dr_Blair.jpg

“Remembering Randa”: Oldest Indian Rhinoceros Within Zoos Worldwide Passes Away at the L.A. Zoo at Age 48

November 10, 2017
Category: Blog

Cancer Survivor, Randa the Rhino, Treated with Xoft System, Served as an Ambassador Animal for Her Species and Helped to Raise over 6,000 for Rhinos in the Wild

On Monday, the L.A. Zoo announced the passing of its 48-year-old Indian rhinoceros, Randa, due to age-related illness. The zoo says Randa was the oldest Indian rhinoceros living in a zoo worldwide and had drawn a... Continue reading

Tags: Skin Cancer Skin eBx Physicians Patients
LA-Zoo-Indian-Rhino-Randa-in-Pool-by-Jamie-Pham.jpg

iCAD Announces Positive Clinical Data on Xoft System for Non-Melanoma Skin Cancer Treatment Selected as “Best of ASTRO 2017”

November 09, 2017
Category: Press Releases

Best of ASTRO meeting recognizes most relevant and highly influential research at ASTRO 2017

NASHUA, N.H. and Miami, Fla., (November 9, 2017) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that clinical research comparing use of the company’s Xoft® Electronic Brachytherapy (eBx®) System® to Mohs surgery in the treatment... Continue reading

iCAD Announces Presentation of New Clinical Data on Xoft System for Treatment of Nonmelanoma Skin Cancer and Early-Stage Breast Cancer at ASTRO 2017

September 25, 2017
Category: Press Releases

Company will also host in-booth expert presentations and active peer-to-peer learning opportunities to review optimal strategies to improve outcomes in patient care using the Xoft System

NASHUA, NH and SAN DIEGO, CA (Booth #3139) – September 25, 2017 – iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and trea... Continue reading

iCAD Announces Approval of Xoft® Axxent® Balloon Applicators by China Food & Drug Administration for Treatment of Early-Stage Breast Cancer

August 30, 2017
Category: Press Releases

Availability of full suite of Xoft System products in China represents significant milestone in expanding global access to advanced technology to treat range of cancers

NASHUA, NH – August 30, 2017 - iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the company’s X... Continue reading

Researchers to Present Clinical Data Supporting Use of Xoft System for Endometrial Cancer Treatment at American Association of Physicists in Medicine Annual Meeting & Exhibition

July 27, 2017
Category: Press Releases

Preliminary results show targeted approach reduces toxicity to organs at risk

NASHUA, NH and DENVER, CO (Booth #6010) July 27, 2017 - iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that researchers will present clinical data supporting use of the Xoft® Axxent® Electr... Continue reading

iCAD announces positive study results comparing use of company’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® to Mohs surgery in treatment of early-stage non-melanoma skin cancer

July 19, 2017
Category: Press Releases

Results of breakthrough study published in peer-reviewed Journal of Contemporary Brachytherapy showed no statistically significant difference in recurrence of cancer at mean follow-up of 3.4 years

NASHUA, NH – July 19, 2017 - iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today an... Continue reading

First-Ever European Analysis of Electronic Brachytherapy Using the Xoft System for Endometrial and Cervical Cancer Treatment to be Presented at European Society for Radiotherapy & Oncology Meeting

May 05, 2017
Category: Press Releases

Preliminary results show targeted treatment offers low toxicity for patients with endometrial or cervical cancer

NASHUA, NH and VIENNA, AUSTRIA (Booth #4330) May 5, 2017 - iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced researchers will present new clinical data suppo... Continue reading

iCAD Announces First Early-Stage Breast Cancer Patient Treated with Intraoperative Radiation Therapy Using the Xoft System at Monash Cancer Centre, a partnership between Peter MacCallum Cancer Centre and Monash Health in Australia

May 01, 2017
Category: Press Releases

First installation of advanced, multi-platform Xoft System in Australia increases global access to versatile, clinically proven technology

NASHUA, NH and Melbourne, Australia – May 1, 2017 – iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced the first early-stage breast... Continue reading

iCAD to Showcase Breakthrough Early-Stage Breast Cancer Treatment Utilizing the Xoft System at American Society of Breast Surgeons (ASBrS) Annual Meeting

April 26, 2017
Category: Press Releases

Company to host in-booth presentations by clinical experts to review recent experience with one-day intraoperative radiation therapy

NASHUA, NH and LAS VEGAS, NV (Booth #101) – April 26, 2017 - iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced the Company will showcase... Continue reading

©2018 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.  Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.